可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] 丁嵩,何奔. 脑钠尿肽在急性冠脉综合征的应用进展[J]. 心脏杂志, 2006, 18(1):103-105.
[2] 丁嵩,何奔,卜军,等. 急性冠脉综合征TIMI风险积分与脑钠尿肽及临床预后的关系[J]. 心脏杂志, 2006, 18(4):417-421.
[3] Rothenbacher D, Koenig W, Brenner H. Comparison of Nterminal proBnatriuretic peptide, Creactive protein, and creatinine clearance for prognosis in patients with known coronary heart disease[J]. Arch Intern Med, 2006, 166(22):2455-2460.
[4] Sakai H, Tsutamoto T, Ishikawa C, et al. Direct comparison of brain natriuretic peptide (BNP) and Nterminal proBNP secretion and extent of coronary artery stenosis in patients with stable coronary artery disease[J]. Circ J, 2007, 71(4):499-505.
[5]de Winter RJ, Stroobants A, Koch KT, et al. Plasma Nterminal proBtype natriuretic peptide for prediction of death or nonfatal myocardial infarction following percutaneous coronary intervention[J]. Am J Cardiol, 2004, 94(12):1481-1485.
[6] Galvani M, Ferrini D, Ottani F. Natriuretic peptides for risk stratification of patients with acute coronary syndromes[J]. Eur J Heart Fail, 2004, 6(3):327-333.
[7] Saleh N, Braunschweig F, Jensen J, et al. Usefulness of preprocedural serum Nterminal probrain natriuretic peptide levels to predict longterm outcome after percutaneous coronary intervention in patients with normal troponin T levels[J]. Am J Cardiol, 2006, 97(6):830-834.
[8] Kragelund C, Gronning B, Kober L, et al. Nterminal proBtype natriuretic peptide and longterm mortality in stable coronary heart disease[J]. N Engl J Med, 2005, 352(7):666-675.
[9] Hong SN, Ahn Y, Yoon NS, et al. Usefulness of serum Nterminal probrain natriuretic peptide to predict instent restenosis in patient with preserved left ventricular function and normal roponinI levels[J]. Am J Cardiol, 2007, 99(8):1051-1054.
[10]姚道阔,王雷,李虹伟,等. 血浆脑钠素对ST段抬高型急性心肌梗死心肌灌注的预测[J]. 山东医药, 2007, 47(1):65-66.
[11]Iwakura K, Ito H, Kawano S, et al. Assessing myocardial perfusion with the transthoracic Doppler technique in patients with reperfused anterior myocardial infarction: comparison with angiographic, enzymatic and electrocardiographic indices[J]. Eur Heart J, 2004 , 25(17):1526-1533.
[12]Hong SN, Ahn Y, Hwang SH, et al. Usefulness of preprocedural Nterminal probrain natriuretic peptide in predicting angiographic noreflow phenomenon during stent implantation in patients with STsegment elevation acute myocardial infarction[J]. Am J Cardiol, 2007, 100(4):631-634.